AA
ORGO icon

AQR Arbitrage’s Organogenesis Holdings ORGO Stock Holding History

AQR Arbitrage’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-200,000
Closed -$2M – 375
2017
Q3 		$2M Sell
200,000
-155,300
-44% -$1.54M 0.02% 200
2017
Q2 		$3.5M Sell
355,300
-44,700
-11% -$439K 0.04% 196
2017
Q1 		$3.98M Buy
+400,000
New +$3.95M 0.04% 180

Other funds holding ORGO

GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
AGC
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
ACPU
Arrowgrass Capital Partners (US) Dover, Delaware $380M AUM 20.87% 1-Year Est. Return
GL
Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

AQR Arbitrage's ORGO Position: Q4 2017 in Review

AQR Arbitrage sold out of Organogenesis Holdings (ORGO) in Q4 2017, closing a stake of 200,000 shares — an estimated $2M sold.

AQR Arbitrage first reported a position in ORGO in Q1 2017 and held it in 3 quarters. The position peaked at $3.98M in Q1 2017. 27 funds tracked by Wall St. Rank hold ORGO as of Q4 2017.

  • AQR Arbitrage reported no remaining Organogenesis Holdings position as of Q4 2017 after selling out during the quarter.
  • AQR Arbitrage sold 200,000 Organogenesis Holdings shares in Q4 2017, an estimated $2M.
  • AQR Arbitrage first reported a position in Organogenesis Holdings in Q1 2017 and held it in 3 quarters.
  • AQR Arbitrage's Organogenesis Holdings position peaked at $3.98M in Q1 2017.
  • 27 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q4 2017.

Based on AQR Arbitrage's 13F filing for Q4 2017, filed 14 Feb 2018.